Providence researchers will begin testing on 36 people as part of a Phase 1 trial of a drug developed in collaboration with two biotech companies -- OncoSec and UbiVac.
Oregon health officials predict they’ll be ready when a vaccine arrives, and federal authorities promise one by early next year. But no one knows how effective or safe it will be and who will get it.
Providers and hospitals across the country reported a dramatic rise in virutal visits this spring, and though in-person visits have since increased, telemedicine is expected to be here to stay.
Health systems worked diligently this spring during the stay-home order creating surge plans to expand capacity, including adding surge beds for patients.
Besides calling for face coverings in all public and private workplaces, the state advises against the use of face shields which do not provide airtight protection against droplets.
In the past two weeks, cases have risen more than 24% in Oregon, a development that marks a "stark reversal" of gains the state had made previously on tamping down the virus spread.